(9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide

C63H63F9N22O6 — CID 159227170

IUPAC(9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide
SMILESCc1ccc2c(NC(=O)N3c4nc(C(=O)C[C@H](C)C(F)(F)F)nc(C)c4N4CC[C@H]3C4)n[nH]c2n1.Cc1ncc(-c2ccnc(NC(=O)N3c4nc(C(=O)CCC(F)(F)F)ncc4N4CC[C@H]3C4)c2)[nH]1.O=C(CCC(F)(F)F)c1ncc2c(n1)N(C(=O)Nc1ccccn1)[C@H]1CCCN2C1
InChIInChI=1S/C22H23F3N8O2.C22H21F3N8O2.C19H19F3N6O2/c1-10(22(23,24)25)8-15(34)19-27-12(3)16-20(28-19)33(13-6-7-32(16)9-13)21(35)29-18-14-5-4-11(2)26-17(14)30-31-18;1-12-27-9-15(29-12)13-3-6-26-18(8-13)30-21(35)33-14-4-7-32(11-14)16-10-28-19(31-20(16)33)17(34)2-5-22(23,24)25;20-19(21,22)7-6-14(29)16-24-10-13-17(26-16)28(12-4-3-9-27(13)11-12)18(30)25-15-5-1-2-8-23-15/h4-5,10,13H,6-9H2,1-3H3,(H2,26,29,30,31,35);3,6,8-10,14H,2,4-5,7,11H2,1H3,(H,27,29)(H,26,30,35);1-2,5,8,10,12H,3-4,6-7,9,11H2,(H,23,25,30)/t10-,13-;14-;12-/m000/s1
InChIKeyKSKZESOAGIOTQJ-GZZIZRMYSA-N
MW1395.33 g/mol
LogP10.91
Rot. Bonds13

About (9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide

(9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide (PubChem CID 159227170) has the molecular formula C63H63F9N22O6 and a molecular weight of 1395.33 g/mol. Its IUPAC name is (9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide.

Molecular Properties

Compound Name(9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide
PubChem CID159227170
Molecular FormulaC63H63F9N22O6
Molecular Weight1395.33 g/mol
Exact Mass1394.52
IUPAC Name(9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide
SMILESCc1ccc2c(NC(=O)N3c4nc(C(=O)C[C@H](C)C(F)(F)F)nc(C)c4N4CC[C@H]3C4)n[nH]c2n1.Cc1ncc(-c2ccnc(NC(=O)N3c4nc(C(=O)CCC(F)(F)F)ncc4N4CC[C@H]3C4)c2)[nH]1.O=C(CCC(F)(F)F)c1ncc2c(n1)N(C(=O)Nc1ccccn1)[C@H]1CCCN2C1
InChIInChI=1S/C22H23F3N8O2.C22H21F3N8O2.C19H19F3N6O2/c1-10(22(23,24)25)8-15(34)19-27-12(3)16-20(28-19)33(13-6-7-32(16)9-13)21(35)29-18-14-5-4-11(2)26-17(14)30-31-18;1-12-27-9-15(29-12)13-3-6-26-18(8-13)30-21(35)33-14-4-7-32(11-14)16-10-28-19(31-20(16)33)17(34)2-5-22(23,24)25;20-19(21,22)7-6-14(29)16-24-10-13-17(26-16)28(12-4-3-9-27(13)11-12)18(30)25-15-5-1-2-8-23-15/h4-5,10,13H,6-9H2,1-3H3,(H2,26,29,30,31,35);3,6,8-10,14H,2,4-5,7,11H2,1H3,(H,27,29)(H,26,30,35);1-2,5,8,10,12H,3-4,6-7,9,11H2,(H,23,25,30)/t10-,13-;14-;12-/m000/s1
InChIKeyKSKZESOAGIOTQJ-GZZIZRMYSA-N
XLogP10.91
TPSA331.32 Ų
H-Bond Donors5
H-Bond Acceptors20
Rotatable Bonds13
Heavy Atoms100
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001395.33
LogP ≤ 510.91
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1020

Analyze (9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide?
The IUPAC name of (9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide (CID 159227170) is (9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide.
What is the SMILES notation for (9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide?
The canonical SMILES for (9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide is Cc1ccc2c(NC(=O)N3c4nc(C(=O)C[C@H](C)C(F)(F)F)nc(C)c4N4CC[C@H]3C4)n[nH]c2n1.Cc1ncc(-c2ccnc(NC(=O)N3c4nc(C(=O)CCC(F)(F)F)ncc4N4CC[C@H]3C4)c2)[nH]1.O=C(CCC(F)(F)F)c1ncc2c(n1)N(C(=O)Nc1ccccn1)[C@H]1CCCN2C1.
What is the InChIKey of (9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide?
The InChIKey is KSKZESOAGIOTQJ-GZZIZRMYSA-N. The full InChI is InChI=1S/C22H23F3N8O2.C22H21F3N8O2.C19H19F3N6O2/c1-10(22(23,24)25)8-15(34)19-27-12(3)16-20(28-19)33(13-6-7-32(16)9-13)21(35)29-18-14-5-4-11(2)26-17(14)30-31-18;1-12-27-9-15(29-12)13-3-6-26-18(8-13)30-21(35)33-14-4-7-32(11-14)16-10-28-19(31-20(16)33)17(34)2-5-22(23,24)25;20-19(21,22)7-6-14(29)16-24-10-13-17(26-16)28(12-4-3-9-27(13)11-12)18(30)25-15-5-1-2-8-23-15/h4-5,10,13H,6-9H2,1-3H3,(H2,26,29,30,31,35);3,6,8-10,14H,2,4-5,7,11H2,1H3,(H,27,29)(H,26,30,35);1-2,5,8,10,12H,3-4,6-7,9,11H2,(H,23,25,30)/t10-,13-;14-;12-/m000/s1.
What are the key properties of (9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide?
(9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide has a molecular weight of 1395.33 g/mol, XLogP of 10.91, 13 rotatable bonds, 5 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for (9S)-N-[4-(2-methyl-1H-imidazol-5-yl)-2-pyridinyl]-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-3-methyl-N-(6-methyl-1H-pyrazolo[5,4-b]pyridin-3-yl)-5-[(3S)-4,4,4-trifluoro-3-methylbutanoyl]-1,4,6,8-tetrazatricyclo[7.2.1.02,7]dodeca-2,4,6-triene-8-carboxamide;(9S)-N-pyridin-2-yl-5-(4,4,4-trifluorobutanoyl)-1,4,6,8-tetrazatricyclo[7.3.1.02,7]trideca-2,4,6-triene-8-carboxamide is sourced from PubChem (CID 159227170), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).